Compare Corning Incorporated (GLW) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs Repligen Corporation Common Stock — how do they compare? Corning Incorporated trades at $134.5 (market cap $121.36B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: Corning Incorporated is far larger — about 10.7× Repligen Corporation Common Stock's market cap, and Corning Incorporated pays a 0.79% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 36 Days and Repligen Corporation Common Stock for 0 Days on average.
| GLW | RGEN | |
|---|---|---|
Market Cap | $121.36B | $11.31B |
Volume | 7,874,233 | 1,216,919 |
Sector | Technology | Health |
52-Week High | $255.79 | $194.57 |
52-Week Low | $78.03 | $102.87 |
Typical Hold Time | 36 Days | 0 Days |
Enterprise Value | $128.24B | $11.20B |
Dividend Yield | 0.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $148.52, up 0.87% with recent earnings beats and a major $3B AT&T fiber deal driving optimism. Technical indicators show bearish momentum with support at $144 and resistance at $153. The company demonstrates strong fundamental improvement with 2025 revenue reaching $15.63B and net income surging to $1.60B, though valuation multiples remain elevated with a P/E of 68.45.
GLW presents growth potential through AI infrastructure demand and fiber expansion, supported by 57% analyst buy ratings and a $171.25 price target. Key risks include patent litigation investigations and high valuation sensitivity to earnings growth. The stock offers 15% upside to consensus target but requires monitoring of legal developments and margin sustainability.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
